Fluoroquinolones for the treatment of pulmonary tuberculosis

Tuberculosis (TB) continues to be a significant problem globally. Treatment includes a multiple drug regimen with isoniazid, rifampicin (rifampin), pyrazinamide and ethambutol. Often, one of these medications needs to be replaced as a result of adverse events or because Mycobacterium tuberculosis de...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drugs (New York, N.Y.) N.Y.), 2007-01, Vol.67 (14), p.2077-2099
Hauptverfasser:	MOADEBI, Susanne, HARDER, Curtis K, FITZGERALD, Mark J, ELWOOD, Kevin R, MARRA, Fawziah
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Antitubercular Agents - therapeutic use Bacterial diseases Bacterial diseases of the respiratory system Biological and medical sciences Causes of Complications and side effects Diagnosis Dosage and administration Drug therapy Drug Therapy, Combination Fluoroquinolones - adverse effects Fluoroquinolones - therapeutic use Health aspects Human bacterial diseases Humans Infectious diseases Medical sciences Mycobacterium tuberculosis Pharmacology. Drug treatments Pulmonary tuberculosis Quinolone antibacterial agents Quinolones Treatment Outcome Tuberculosis and atypical mycobacterial infections Tuberculosis, Multidrug-Resistant - drug therapy Tuberculosis, Pulmonary - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!